These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 17003379
1. Eosinophils are a major intravascular location for tissue factor storage and exposure. Moosbauer C, Morgenstern E, Cuvelier SL, Manukyan D, Bidzhekov K, Albrecht S, Lohse P, Patel KD, Engelmann B. Blood; 2007 Feb 01; 109(3):995-1002. PubMed ID: 17003379 [Abstract] [Full Text] [Related]
2. New locations of intravascular tissue factor: indications. Reinhardt C. Hamostaseologie; 2007 Feb 01; 27(1):55-8. PubMed ID: 17279277 [Abstract] [Full Text] [Related]
3. The effect of transendothelial migration on eosinophil function. Yamamoto H, Sedgwick JB, Vrtis RF, Busse WW. Am J Respir Cell Mol Biol; 2000 Sep 01; 23(3):379-88. PubMed ID: 10970830 [Abstract] [Full Text] [Related]
4. Role of vascular cell adhesion molecule-1 and platelet-activating factor in selective eosinophil migration across vascular endothelial cells. Sano H, Nakagawa N, Nakajima H, Yoshida S, Iwamoto I. Int Arch Allergy Immunol; 1995 Aug 01; 107(4):533-40. PubMed ID: 7542515 [Abstract] [Full Text] [Related]
5. Enhanced tissue factor expression by blood eosinophils from patients with hypereosinophilia: a possible link with thrombosis. Cugno M, Marzano AV, Lorini M, Carbonelli V, Tedeschi A. PLoS One; 2014 Aug 01; 9(11):e111862. PubMed ID: 25375118 [Abstract] [Full Text] [Related]
6. Tumor necrosis factor alpha is necessary for granulocyte-macrophage-colony-stimulating-factor-induced eosinophil transendothelial migration. Erger RA, Casale TB. Int Arch Allergy Immunol; 1998 Jan 01; 115(1):24-32. PubMed ID: 9430492 [Abstract] [Full Text] [Related]
7. Eosinophil transendothelial migration induced by cytokines. II. Potentiation of eosinophil transendothelial migration by eosinophil-active cytokines. Ebisawa M, Liu MC, Yamada T, Kato M, Lichtenstein LM, Bochner BS, Schleimer RP. J Immunol; 1994 May 01; 152(9):4590-6. PubMed ID: 8157972 [Abstract] [Full Text] [Related]
8. No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophils. Sovershaev MA, Lind KF, Devold H, Jørgensen TØ, Hansen JB, Østerud B, Egorina EM. J Thromb Haemost; 2008 Oct 01; 6(10):1742-9. PubMed ID: 18665928 [Abstract] [Full Text] [Related]
9. Eosinophils maintain their capacity to signal and release eosinophil cationic protein upon repetitive stimulation with the same agonist. Simon HU, Weber M, Becker E, Zilberman Y, Blaser K, Levi-Schaffer F. J Immunol; 2000 Oct 01; 165(7):4069-75. PubMed ID: 11034418 [Abstract] [Full Text] [Related]
10. IL-5 enhances the in vitro adhesion of human eosinophils, but not neutrophils, in a leucocyte integrin (CD11/18)-dependent manner. Walsh GM, Hartnell A, Wardlaw AJ, Kurihara K, Sanderson CJ, Kay AB. Immunology; 1990 Oct 01; 71(2):258-65. PubMed ID: 2228026 [Abstract] [Full Text] [Related]
11. Reduced expression of granule proteins during extended survival of eosinophils in splenocyte culture with GM-CSF. Ryu SH, Na HY, Sohn M, Han SM, Choi W, In H, Hong S, Jeon H, Seo JY, Ahn J, Park CG. Immunol Lett; 2016 May 01; 173():7-20. PubMed ID: 26969350 [Abstract] [Full Text] [Related]
12. Growth and differentiation of eosinophils from human peripheral blood CD 34+ cells. Shalit M. Allerg Immunol (Paris); 1997 Jan 01; 29(1):7-10. PubMed ID: 9025988 [Abstract] [Full Text] [Related]
13. Enhanced expression of platelet-activating factor receptor on human eosinophils by interleukin-3, interleukin-5 and granulocyte-macrophage colony-stimulating factor. Kishimoto S, Shimazu W, Izumi T, Shimizu T, Fukuda T, Makino S, Sugiura T, Waku K. Int Arch Allergy Immunol; 1996 Jan 01; 111 Suppl 1():63-5. PubMed ID: 8906117 [Abstract] [Full Text] [Related]
14. GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor. Tomioka K, MacGlashan DW, Lichtenstein LM, Bochner BS, Schleimer RP. J Immunol; 1993 Nov 01; 151(9):4989-97. PubMed ID: 8409452 [Abstract] [Full Text] [Related]
15. Granule protein changes and membrane receptor phenotype in maturing human eosinophils cultured from CD34+ progenitors. Al-Rabia MW, Blaylock MG, Sexton DW, Thomson L, Walsh GM. Clin Exp Allergy; 2003 May 01; 33(5):640-8. PubMed ID: 12752593 [Abstract] [Full Text] [Related]
16. The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils. Tai PC, Spry CJ. Clin Exp Immunol; 1990 Jun 01; 80(3):426-34. PubMed ID: 2197048 [Abstract] [Full Text] [Related]
17. Selective eosinophil leukocyte recruitment by transendothelial migration and not by leukocyte-endothelial cell adhesion. Morland CM, Wilson SJ, Holgate ST, Roche WR. Am J Respir Cell Mol Biol; 1992 May 01; 6(5):557-66. PubMed ID: 1316135 [Abstract] [Full Text] [Related]
18. Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis. Linden M, Svensson C, Andersson M, Greiff L, Andersson E, Denburg JA, Persson CG. Allergy; 1999 Mar 01; 54(3):212-9. PubMed ID: 10321556 [Abstract] [Full Text] [Related]
19. Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate. Boyce JA, Friend D, Matsumoto R, Austen KF, Owen WF. J Exp Med; 1995 Jul 01; 182(1):49-57. PubMed ID: 7540656 [Abstract] [Full Text] [Related]
20. Transmigration of eosinophils through basement membrane components in vitro: synergistic effects of platelet-activating factor and eosinophil-active cytokines. Okada S, Kita H, George TJ, Gleich GJ, Leiferman KM. Am J Respir Cell Mol Biol; 1997 Apr 01; 16(4):455-63. PubMed ID: 9115757 [Abstract] [Full Text] [Related] Page: [Next] [New Search]